BC
RVMD icon

Bayforest Capital’s Revolution Medicines RVMD Stock Holding History

Bayforest Capital’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$185K Buy
+1,905
New +$192K 0.21% 147
2025
Q4 		– Sell
-7,417
Closed -$346K – 931
2025
Q3 		$346K Buy
7,417
+1,301
+21% +$50.9K 0.16% 247
2025
Q2 		$225K Buy
+6,116
New +$235K 0.1% 355

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bayforest Capital's RVMD Position: Q1 2026 in Review

Bayforest Capital opened a new position in Revolution Medicines (RVMD) in Q1 2026: 1,905 shares worth $185K. The stake represents 0.21% of the portfolio and ranks #147 among its holdings. This is a return to the name: Bayforest Capital previously reported a position in RVMD as recently as Q3 2025.

Bayforest Capital first reported a position in RVMD in Q2 2025 and has held it in 3 quarters since. The position peaked at $346K in Q3 2025. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Bayforest Capital held 1,905 shares of Revolution Medicines worth $185K as of Q1 2026.
  • Revolution Medicines was a new Bayforest Capital position in Q1 2026.
  • Revolution Medicines made up 0.21% of Bayforest Capital's portfolio in Q1 2026, its #147 holding.
  • Bayforest Capital first reported a position in Revolution Medicines in Q2 2025 and has held it in 3 quarters since.
  • Bayforest Capital's Revolution Medicines position peaked at $346K in Q3 2025.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Bayforest Capital's 13F filing for Q1 2026, filed 15 Apr 2026.